Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells

Radiation Research

Volumn 146, Issue 4, 1996, Pages 444-452

  Dees, Craig ^a   Garrett, Scott ^b   Henley, Don ^c   Travis, Curtis ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DNA DETERMINATION; ELECTROMAGNETIC FIELD; ELECTROMAGNETIC RADIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0029784391     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579306     Document Type: Article

References (34)

1. C. E. Easterly, Cancer link to magnetic field exposure: a hypothesis. Am. J. Epidemiol. 114, 169-174 (1981).
2. T. E. Aldrich and C. E. Easterly, Electromagnetic fields and public health. Environ. Health. Perspect. 75, 159-171 (1987).
3. R. G. Stevens, Electric power use and breast cancer: a hypothesis. Am. J. Epidemiol. 125, 556-561 (1987).
4. R. P. Liburdy, T. R. Sloma, R. Sokolic and P. Yaswen, ELF magnetic fields, breast cancer, melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cells. J. Pineal Res. 14, 89-87 (1993).
5. M. Pagano, R. Pepperkok, J. Lukas, V. Baldwin, W. Ansorge, J. Bartek and G. Draetta, Regulation of the cell cycle by the Cdk2 protein kinase in cultured human fibroblasts. J. Cell. Biol. 121, 101-111 (1993).
6. T. Akiyama, T. Ohuchuy, S. Sumida, K. Matsumoto and K. Toyoshima, Phosphorylation of the retinoblastoma protein by Cdk2. Proc. Natl. Acad. Sci. USA 89, 7900-7904 (1992).
7. C. Dees, M. Askari, S. Garrett, K. Gehrs, D. Henley, C. M. Ardies and C. Travis, A role for the synthetic food colorant Red Dye No. 3 in human breast cancer. Environ. Health. Perspect. in press.
8. C. Dees and C. Travis, Benzene, toluene and chloroform induced hyperphosphorylation of p53. Cancer Lett. 84, 117-123 (1994).
9. J. Yatsunami, A. Komori, T. Ohta, M. Suganuma and H. Fujiki, Hyperphosphorylation of retinoblastoma protein and p53 by okadiac acid, a tumor promoter. Cancer Res. 53, 239-241 (1993).
10. J. R. Bishoff, P. N. Friedman, D. R. Marshak, C. Prives and D. Beach, Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. USA 87, 4766-4770 (1988).
11. V. Kumar and P. Chambon, The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55, 145-156 (1988).
12. C. Dees and C. Travis, Increased p53 site-specific DNA binding in cells producing mutant p53. Cancer Lett. 96, 225-231 (1995).
13. R. B. Tishler, S. K. Calderwood, C. N. Coleman and B. D. Price, Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53, 2212-2216 (1993).
14. 2+-dependent protein kinase in human breast cancer cells. Int. J. Cancer 37, 731-737 (1986).
15. W. D. Funk, D. T. Pak, R. H. Karas, W. S. Wright and J. W. Shay, A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12, 2866-2871 (1992).
16. J. S. Foster and J. Wimalasena, Estrogen and antiestrogen regulate cyclin dependent kinase 2 (Cdk2) activity and retinoblastoma protein phosphorylation in MCF-7 breast cancer cells. Mol. Endocrinol. 10, 488-498 (1996).
17. M. Ayala, R. F. Balint, M. E. Fernandez-de-Cossio, L. Canaan-Haden, J. W. Larrick and J. V. Gavilondo, New primer strategy improves precision of differential display. BioTechniques 18, 840-850 (1995).
18. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14, 6264-6277 (1994).
19. H. Matsumoto, M. Shimura, T. Omatsu, K. Okaichi, H. Majima and T. Ohnishi, p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. Cancer Lett. 87, 39-46 (1994).
20. L. Jayaraman and C. Prives, Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81, 1021-1029 (1995).
21. S. Lee, B. Elenbass, A. Levine and J. Griffith, p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81, 1013-1020 (1995).
22. A. M. Soto, K. L. Chung and C. Sonnenschein. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ. Health. Perspect. 102, 380-383 (1995).
23. W. Lösher and M. Mevissen, Linear relationship between flux density and tumor co-promoting effect of prolonged magnetic field exposure in a breast cancer model. Cancer Lett. 96, 175-180 (1995).
24. J. D. Saffer and S. J. Thurston, Cancer risk and electromagnetic fields. Nature 374, 22 (1995).
25. J. D. Saffer and S. J. Thurston, Short exposures to 60 Hz magnetic fields do not alter MYC expression in HL60 or Daudi cells. Radiat. Res. 144, 18-25 (1995).
26. E. Marshall, Search for a killer: focus shifts from fat to hormones. Science 259, 618-621 (1993). [Special Report]
27. J. R. Harris, M. E. Lippman, U. Veronesi and W. Willet, Breast cancer. N Engl. J. Med. 327, 319-328 (1992).
28. W. C. Willett, What should we eat? Science 264, 532-537 (1994).
29. D. L. Davis, H. L. Bradlow, M. Wolff, T. Woodruff, D. G. Hoel and H. Anto-Culver, Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect. 101, 372-377 (1993).
30. M. Lippman, M. E. Monaco and R. B. Dickson, Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog. Horm. Res. 45, 383-440 (1989).
31. F. S. von Saal, Environmental estrogenic chemicals: their impact on embryonic development. Hum. Ecol. Risk Assess. 1, 3-15 (1995).
32. S. H. Safe, Do environmental estrogens play a role in development of breast cancer in women and male reproductive problems? Hum. Ecol. Risk Assess. 1, 17-23 (1995).
33. G. Taubes, Another blow weakens EMF-cancer link. Science 269, 1816-1817 (1995). [News]
34. A. Lacy-Hulbert, R. C. Wilkins, T. R. Hesketh and J. C. Metcalfe, No effect of 60 Hz electromagnetic fields on MYC or β-actin expression in human leukemic cells. Radiat. Res. 144, 9-17 (1995).